(1 - 17 von 38
)
FDA slaps clinical hold on Foghorn blood cancer trial
www.pharmamanufacturing.com
— About the hold, Foghorn CEO Adrian Gottschalk said, “Patient safety remains our top priority. We appreciate the dialogue with the FDA and ... › ...
Lilly and Foghorn Announce Strategic… - Flagship Pioneering
www.flagshippioneering.com
— ... approach to create medicines targeting genetic dependencies within the chromatin regulatory system,” said Foghorn CEO Adrian Gottschalk. › ...
sortiert nach Relevanz / Datum